Firoozeh Sahebi

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

David G. Maloney, Arthur J. Molina, Firoozeh Sahebi et al. · Blood · 2003 · 407 citations · Full text

Medicine, Oncology, Transplant Immunology +11

Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

Mohamed L. Sorror, Brenda M. Sandmaier, Barry E. Storer et al. · JAMA · 2011 · 320 citations · Full text

Medicine, Geriatric Medicine, Hematology +15

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

Amrita Krishnan, Marcelo C. Pasquini, Brent R. Logan et al. · The Lancet Oncology · 2011 · 277 citations

Medicine, Hematology, Oncology +15

Transplantation of CD34+ peripheral blood progenitor cells after high- dose chemotherapy for patients with advanced multiple myeloma

Gary J. Schiller, Robert Vescio, César O. Freytes et al. · Blood · 1995 · 258 citations · Full text

Medicine, Hematology, Oncology +16

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

Rainer Storb, Boglarka Gyurkocza, Barry E. Storer et al. · Journal of Clinical Oncology · 2013 · 212 citations · Full text

Medicine, Hematology, Immunology +15